FOLLICLE STIMULATING HORMONE (FSH)

The Follicle Stimulating Hormone (FSH) test measures circulating FSH from a venous blood sample to assess ovarian reserve and overall hypothalamic–pituitary–ovarian hormonal balance, and is commonly performed on day 2–4 of the menstrual cycle when used for fertility evaluation. It is useful for women investigating infertility, irregular menstruation or suspected early menopause and helps clinicians estimate ovarian response and plan appropriate fertility or hormonal treatments. We offer convenient at‑home sample collection across Dubai with analysis by accredited UAE laboratories and secure reporting — always review results with your healthcare provider for accurate interpretation and next steps.

• Follicle Stimulating Hormone (FSH)
• Sample: Venous blood (serum)
• Method: Quantitative immunoassay
• Turnaround time: 24–48 hours
• Accredited UAE lab (DHA/CAP/ISO)

• Quantitative FSH blood test to evaluate ovarian reserve and menopausal status
• Home sample collection by trained phlebotomist across Dubai with DHA‑accredited laboratory analysis
• Cycle‑timed testing (recommended on cycle days 2–4) with flexible scheduling and collection reminders
• Secure digital report with numeric result, UAE reference ranges and clinical interpretation notes
• Suitable for fertility assessments, IVF planning and baseline hormonal screening

• Quantitative serum FSH measurement processed by accredited diagnostic laboratories in the UAE for accurate hormone assessment
• At‑home phlebotomy service across Dubai with flexible booking and secure, traceable sample transport
• Certified lab report with standard reference ranges and clinical interpretation notes, ready for your physician
• Helps assess ovarian reserve, fertility planning, menstrual irregularities and perimenopausal evaluation
• Fast turnaround—results typically within 24–48 hours with optional teleconsultation with fertility or endocrine specialists

• At‑home venous blood collection by licensed phlebotomists across Dubai
• Recommended on menstrual cycle day 2–4 for ovarian reserve assessment; can be performed anytime for menopausal evaluation
• No fasting required; quick, minimally invasive sample collection
• Analysis by DHA & ISO‑accredited labs with detailed report and optional specialist teleconsultation